ArticleClinical drug investigation2011

Effects of adalimumab versus placebo on risk of symptom worsening in psoriasis and subsequent impacts on health-related quality-of-life: analysis of pooled data from two randomized, double-blind, placebo-controlled, multicentre clinical trials.

Kim A Papp et al.PubMed ↗Publisher ↗

No numbers read from the abstract.